Island Pharmaceuticals Limited ACN 641 183 842 | Registered office: Level 1 Suite 1, 117 Camberwell Road, Hawthorn East VIC 3123 Australia Page 1 of 2 13 August 2026 ASX Announcement DATE OF ANNUAL GENERAL MEETING AND CLOSING DATE FOR DIRECTOR NOMINATIONS ...
Date of AGM & Closing Date for Director Nominations
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Island Pharmaceuticals Ltd has announced the date for its Annual General Meeting and the closing date for director nominations. The AGM is scheduled for a date in October, and nominations for directors must be submitted by a specified date in August. This announcement was authorized by the CEO and Managing Director, David Foster.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Island Pharmaceuticals Ltd on 6ix
Earlier from Island Pharmaceuticals
- Cleansing Notice
- Application for quotation of securities - ILA
- Investor presentation
- Quarterly Appendix 4C and Activities Report
- Texas Biomed SOW accelerates pivotal FDA pathway
Later from Island Pharmaceuticals
- Island boosts Galidesivir supply as Ebola surges
- Preliminary Final Report
- Annual Report to shareholders
- Appendix 4G and Corporate Governance Statement
- Pivotal Marburg data secured for Galidesivir FDA pathway
Follow Island Pharmaceuticals into a list and get an email when it puts out news.
Follow Island Pharmaceuticals